ICD Code T38.3X5A

ICD code T38.3X5A is used to indicate an initial encounter for a patient experiencing an adverse effect from insulin or oral antidiabetic drugs.

1. Patient is currently experiencing an adverse effect following the administration of insulin or oral hypoglycemic (antidiabetic) drugs.

2. Symptoms may include hypoglycemia, allergic reactions, or other negative physiological responses directly linked to the medication.

3. The encounter is the initial assessment or treatment for this adverse effect.

4. There is clear documentation that the reaction is due to the proper use of the medication, not due to overdose, misuse, or error.

5. No evidence of intentional self-harm or poisoning; the effect is unintended and related to therapeutic use.

Relevant CPT codes that may be used to treat ICD code T38.3X5A include:

- 99221–99223 (Initial hospital care, per day, for the evaluation and management of a patient)

- 99231–99233 (Subsequent hospital care, per day, for the evaluation and management of a patient)

- 99238–99239 (Hospital discharge day management)

- 96365 (Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour)

- 96374 (Therapeutic, prophylactic, or diagnostic injection [IV push]; single or initial substance/drug)

- 82947 (Glucose; quantitative, blood [except reagent strip])

- 82948 (Glucose; blood, reagent strip)

- 83036 (Hemoglobin; glycosylated [A1C])

- 36415 (Collection of venous blood by venipuncture)

These CPT codes are commonly associated with the management and treatment of conditions represented by ICD code T38.3X5A.

Schedule a demo to see how MD Clarity’s RevFind software can automatically read your payer contracts and identify underpayments for CPT codes associated with ICD code T38.3X5A. Discover how easy it is to ensure you’re being paid accurately for every encounter—book your personalized walkthrough today.